STAAR Surgical Company announced preliminary net sales for the first quarter ended March 29, 2024, are expected to be in excess of $77 million with U.S....
Trinity Biotech plc announced results for the quarter ended December 31, 2023 and fiscal year 2023 and key business updates. Business updates Comprehensive transformation plan At...
Prenosis, Inc. announced the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the Sepsis ImmunoScore™ using the De Novo pathway. The Sepsis ImmunoScore™...
T-Hub on Wednesday announced its strategic partnership with Medtronic. The collaboration marks a significant leap forward in fostering innovation and growth within India’s dynamic health-tech startup...
Asensus Surgical, Inc. announced that it has entered into a non-binding letter of intent with KARL STORZ SE & Co. KG to engage in diligence and...
Medcura, Inc. announced that it has closed a private placement with aggregate gross proceeds of US $22.4 million in Convertible Debt. The Company intends to use...
Clario announced the acquisition of the technology company ArtiQ. This acquisition expands the power of artificial intelligence (AI) in Clario’s Respiratory Solutions portfolio and enhances the...
HemoSonics announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its...
Affinity Biosensors announced that its groundbreaking LifeScale AST system has received FDA clearance. This milestone gives healthcare professionals an important tool for managing bacteremia by providing...
Haemonetics Corporation announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the TEG® 6s hemostasis analyzer system Global Hemostasis-HN...
QuidelOrtho Corporation has received U.S. Food and Drug Administration 510(k) clearance for its QuickVue COVID-19 test. This clearance allows the test to be used with accuracy...
Aragen announced that it has operationalized the first phase of its biologics manufacturing facility in Bangalore, India through its 100% subsidiary, Aragen Biologics Pvt Ltd. The...
Genmab and ProfoundBio, Inc. announced that the companies have entered into a definitive agreement for Genmab to acquire ProfoundBio in an all-cash transaction. ProfoundBio is a...
ARCA biopharma, Inc. and Oruka Therapeutics announced that they have entered into a definitive agreement to combine the companies in an all-stock transaction. The resulting entity...
Praia Health announced the closing of a $20 million oversubscribed Series A financing led by Frist Cressey Ventures and backed by SignalFire, Epsilon Health Investors and...
Copyright © 2024 Medical Buyer